Gentris Corporation, a global provider of applied clinical pharmacogenomic services and diagnostic product solutions, announced the availability of Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6).
Gentris Corporation, a global provider of applied clinical pharmacogenomic services and diagnostic product solutions, announced the availability of Human Genomic DNA Reference Controls for the Cytochrome P450 2D6 gene (CYP2D6).
